Regulation of angiogenesis during osseointegration by titanium surface microstructure and energy
Source abstract
Abstract
Rough titanium (Ti) surface microarchitecture and high surface energy have been shown to increase osteoblast differentiation, and this response occurs through signaling via the alpha(2)beta(1) integrin. However, clinical success of implanted materials is dependent not only upon osseointegration but also on neovascularization in the peri-implant bone. Here we tested the hypothesis that Ti surface microtopography and energy interact via alpha(2)beta(1) signaling to regulate the expression of angiogenic growth factors. Primary human osteoblasts (HOB), MG63 cells and MG63 cells silenced for alpha(2) integrin were cultured on Ti disks with different surface microtopographies and energies. Secreted levels of vascular endothelial growth factor-A (VEGF-A), basic fibroblast growth factor (FGF-2), epidermal growth factor (EGF), and angiopoietin-1 (Ang-1) were measured. VEGF-A increased 170% and 250% in MG63 cultures, and 178% and 435% in HOB cultures on SLA and modSLA substrates, respectively. In MG63 cultures, FGF-2 levels increased 20 and 40-fold while EGF increased 4 and 6-fold on SLA and modSLA surfaces. These factors were undetectable in HOB cultures. Ang-1 levels were unchanged on all surfaces.Media from modSLA MG63 cultures induced more rapid differentiation of endothelial cells and this effect was inhibited by anti-VEGF-A antibodies. Treatment of MG63 cells with 1 alpha,25(OH)(2)D3 enhanced levels of VEGF-A on SLA and modSLA.Silencing the alpha(2) integrin subunit increased VEGF-A levels and decreased FGF-2 levels. These results show that Ti surface microtopography and energy modulate secretion of angiogenic growth factors by osteoblasts and that this regulation is mediated at least partially via alpha(2)beta(1) integrin signaling.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Bone and Dental Protein Studies · Orthopaedic implants and arthroplasty
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Third-generation biomedical materials10.1126/science.1067404 ↗
2. Gene activation by bioactive glasses10.1007/s10856-006-0435-9 ↗
3. Nanotopography: cellular responses to nanostructured materials10.1166/jnn.2006.330 ↗
4. The initial attachment and subsequent behavior of osteoblastic cells and oral epithelial cells on titanium
5. Pretreatment of bone with osteoclasts affects phenotypic expression of osteoblast-like cells10.1016/S0736-0266(02)00261-9 ↗
6. High surface energy enhances cell response to titanium substrate microstructure10.1002/jbm.a.30320 ↗
7. Influence of surface characteristics on bone integration of titanium implants. A histomorphometric study in miniature pigs10.1002/jbm.820250708 ↗
8. Anchorage of TiO2-blasted, HA-coated, and machined implants: an experimental study with rabbits10.1002/jbm.820291009 ↗
9. Bone response to unloaded and loaded titanium implants with a sandblasted and acid-etched surface: a histometric study in the canine mandible10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q ↗
10. Integrins: bidirectional, allosteric signaling machines10.1016/S0092-8674(02)00971-6 ↗
11. Response of human osteoblasts to implant materials: integrin-mediated adhesion10.1002/jor.1100140606 ↗
12. 1alpha,25(OH)2D3 regulation of integrin expression is substrate dependent10.1002/jbm.a.30134 ↗
13. Integrin alpha2beta1 plays a critical role in osteoblast response to micron-scale surface structure and surface energy of titanium substrates10.1073/pnas.0805420105 ↗
14. Integrin beta1 silencing in osteoblasts alters substrate-dependent responses to 1,25-dihydroxy vitamin D310.1016/j.biomaterials.2006.02.022 ↗
15. Impaired angiogenesis, early callus formation, and late stage remodeling in fracture healing of osteopontin-deficient mice10.1359/jbmr.061103 ↗
16. Angiogenesis in bone fracture healing: a bioregulatory model10.1016/j.jtbi.2007.11.008 ↗
17. In vivo analysis of biocompatibility and vascularization of the synthetic bone grafting substitute NanoBone(R)
18. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis10.1172/JCI114322 ↗
19. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth10.1038/325257a0 ↗
20. HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways10.1080/08977190701773070 ↗
21. Angiopoietin-1 induces sprouting angiogenesis in vitro10.1016/S0960-9822(98)70205-2 ↗
22. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation10.1210/endo.141.5.7458 ↗
23. Evaluation of VEGF-mediated signaling in primary human cells reveals a paracrine action for VEGF in osteoblast-mediated crosstalk to endothelial cells10.1002/jcp.21234 ↗
24. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation10.1242/jcs.113.1.59 ↗
25. Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo10.1111/j.1476-5381.1993.tb13553.x ↗
26. VEGF/Flk-1 interaction, a requirement for malignant ascites recurrence10.1089/10799900050023933 ↗
27. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor10.1016/0741-5214(92)90106-I ↗
28. Epidermal growth factor receptor at endothelial cell and pericyte interdigitation in human granulation tissue10.1016/0026-2862(92)90085-4 ↗
29. Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate10.1002/j.1939-4640.2001.tb02199.x ↗
30. The angiopoietin/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy10.1167/iovs.07-1206 ↗
31. Anabolic effects of 1,25-dihydroxyvitamin D3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells10.1210/endo.138.7.5275 ↗
32. Expression and regulation of basic fibroblast growth factor mRNA levels in mouse osteoblastic MC3T3-E1 cells10.1016/S0021-9258(17)37121-1 ↗
33. The direct role of vitamin D on bone homeostasis10.1016/j.abb.2008.03.038 ↗
34. Osteoinductivity of demineralized bone matrix in immunocompromised mice and rats is decreased by ovariectomy and restored by estrogen replacement10.1016/j.bone.2006.07.022 ↗
35. Use of bone morphogenetic protein 2 on ectopic porous coated implants in the rat
36. Effect of micrometer-scale roughness of the surface of Ti6Al4V pedicle screws in vitro and in vivo10.2106/JBJS.G.00499 ↗
37. Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation10.1002/jcb.20462 ↗
38. Enhancing surface free energy and hydrophilicity through chemical modification of microstructured titanium implant surfaces10.1002/jbm.a.30518 ↗
39. Effect of titanium surface roughness on proliferation, differentiation, and protein synthesis of human osteoblast-like cells (MG63)10.1002/jbm.820290314 ↗
40. Differentiation and cytokine synthesis of human alveolar osteoblasts compared to osteoblast-like cells (MG63) in response to titanium surfaces10.1016/j.dental.2007.03.001 ↗
41. Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering10.1002/jor.20402 ↗
42. The influence of donor and hypoxic conditions on the assembly of cartilage matrix by osteoarthritic human articular chondrocytes on Hyalograft matrices10.1016/j.biomaterials.2008.09.064 ↗
43. Owen · Endocrinology · 1991 · 128 · 149610.1210/endo-128-3-1496 ↗
44. Osteoblasts generate an osteogenic microenvironment when grown on surfaces with rough microtopographies10.22203/eCM.v006a03 ↗
45. Integrins as linker proteins between osteoblasts and bone replacing materials. A critical review10.1016/j.biomaterials.2004.02.021 ↗